nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—hypothyroidism—thyroid cancer	0.538	1	CtDrD
Levothyroxine—THRB—thyroid cancer	0.343	1	CbGaD
Levothyroxine—ALB—Vandetanib—thyroid cancer	0.0184	0.386	CbGbCtD
Levothyroxine—CYP2C8—Sorafenib—thyroid cancer	0.00856	0.18	CbGbCtD
Levothyroxine—ABCB1—Sorafenib—thyroid cancer	0.00579	0.122	CbGbCtD
Levothyroxine—CYP3A4—Vandetanib—thyroid cancer	0.00576	0.121	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—thyroid cancer	0.00351	0.0739	CbGbCtD
Levothyroxine—CYP3A4—Sorafenib—thyroid cancer	0.00347	0.0729	CbGbCtD
Levothyroxine—SERPINA7—neck—thyroid cancer	0.00221	0.0957	CbGeAlD
Levothyroxine—CYP3A4—Doxorubicin—thyroid cancer	0.00211	0.0443	CbGbCtD
Levothyroxine—Dextrothyroxine—THRB—thyroid cancer	0.0015	0.439	CrCbGaD
Levothyroxine—THRA—neck—thyroid cancer	0.00137	0.0591	CbGeAlD
Levothyroxine—THRB—neck—thyroid cancer	0.00137	0.0591	CbGeAlD
Levothyroxine—SLC16A2—neck—thyroid cancer	0.00124	0.0536	CbGeAlD
Levothyroxine—Hyperthyroidism—Sorafenib—thyroid cancer	0.00116	0.0578	CcSEcCtD
Levothyroxine—Liotrix—THRB—thyroid cancer	0.00111	0.324	CrCbGaD
Levothyroxine—THRB—saliva-secreting gland—thyroid cancer	0.00107	0.0461	CbGeAlD
Levothyroxine—SERPINA7—thyroid gland—thyroid cancer	0.00105	0.0456	CbGeAlD
Levothyroxine—TTR—neck—thyroid cancer	0.00102	0.044	CbGeAlD
Levothyroxine—SLCO4C1—trachea—thyroid cancer	0.000858	0.0371	CbGeAlD
Levothyroxine—SLC7A5—saliva-secreting gland—thyroid cancer	0.000814	0.0352	CbGeAlD
Levothyroxine—Liothyronine—THRB—thyroid cancer	0.000811	0.237	CrCbGaD
Levothyroxine—SLC16A2—trachea—thyroid cancer	0.000745	0.0322	CbGeAlD
Levothyroxine—THRA—thyroid gland—thyroid cancer	0.000651	0.0281	CbGeAlD
Levothyroxine—THRB—thyroid gland—thyroid cancer	0.000651	0.0281	CbGeAlD
Levothyroxine—SLC7A5—trachea—thyroid cancer	0.000628	0.0271	CbGeAlD
Levothyroxine—SLC16A2—thyroid gland—thyroid cancer	0.00059	0.0255	CbGeAlD
Levothyroxine—THRA—head—thyroid cancer	0.000577	0.025	CbGeAlD
Levothyroxine—THRB—head—thyroid cancer	0.000577	0.025	CbGeAlD
Levothyroxine—SLCO4A1—trachea—thyroid cancer	0.000548	0.0237	CbGeAlD
Levothyroxine—SLCO1C1—thyroid gland—thyroid cancer	0.000541	0.0234	CbGeAlD
Levothyroxine—SLC16A2—head—thyroid cancer	0.000523	0.0226	CbGeAlD
Levothyroxine—Hypoglycaemia—Vandetanib—thyroid cancer	0.000506	0.0252	CcSEcCtD
Levothyroxine—Cardiac failure—Vandetanib—thyroid cancer	0.000506	0.0252	CcSEcCtD
Levothyroxine—SLC7A5—thyroid gland—thyroid cancer	0.000497	0.0215	CbGeAlD
Levothyroxine—TTR—thyroid gland—thyroid cancer	0.000484	0.0209	CbGeAlD
Levothyroxine—SLCO1C1—head—thyroid cancer	0.00048	0.0208	CbGeAlD
Levothyroxine—Cardiac arrest—Vandetanib—thyroid cancer	0.000469	0.0234	CcSEcCtD
Levothyroxine—Dehydration—Vandetanib—thyroid cancer	0.000459	0.0229	CcSEcCtD
Levothyroxine—SLC7A5—head—thyroid cancer	0.000441	0.0191	CbGeAlD
Levothyroxine—SLCO4A1—thyroid gland—thyroid cancer	0.000434	0.0188	CbGeAlD
Levothyroxine—TTR—head—thyroid cancer	0.000429	0.0186	CbGeAlD
Levothyroxine—Dysphagia—Vandetanib—thyroid cancer	0.000427	0.0212	CcSEcCtD
Levothyroxine—THRB—lymph node—thyroid cancer	0.000404	0.0175	CbGeAlD
Levothyroxine—THRA—lymph node—thyroid cancer	0.000404	0.0175	CbGeAlD
Levothyroxine—Weight decreased—Vandetanib—thyroid cancer	0.000386	0.0192	CcSEcCtD
Levothyroxine—SLCO4A1—head—thyroid cancer	0.000385	0.0166	CbGeAlD
Levothyroxine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.000367	0.0183	CcSEcCtD
Levothyroxine—SLC16A2—lymph node—thyroid cancer	0.000366	0.0158	CbGeAlD
Levothyroxine—Cardiac failure—Sorafenib—thyroid cancer	0.000341	0.017	CcSEcCtD
Levothyroxine—SLCO1C1—lymph node—thyroid cancer	0.000336	0.0145	CbGeAlD
Levothyroxine—Mood swings—Sorafenib—thyroid cancer	0.000316	0.0157	CcSEcCtD
Levothyroxine—Dehydration—Sorafenib—thyroid cancer	0.00031	0.0154	CcSEcCtD
Levothyroxine—SLC7A5—lymph node—thyroid cancer	0.000308	0.0133	CbGeAlD
Levothyroxine—Arrhythmia—Vandetanib—thyroid cancer	0.000305	0.0152	CcSEcCtD
Levothyroxine—Alopecia—Vandetanib—thyroid cancer	0.000302	0.015	CcSEcCtD
Levothyroxine—Dysphagia—Sorafenib—thyroid cancer	0.000288	0.0143	CcSEcCtD
Levothyroxine—Tremor—Vandetanib—thyroid cancer	0.000279	0.0139	CcSEcCtD
Levothyroxine—SLCO1A2—head—thyroid cancer	0.000275	0.0119	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—thyroid cancer	0.000269	0.0117	CbGeAlD
Levothyroxine—Weight decreased—Sorafenib—thyroid cancer	0.00026	0.013	CcSEcCtD
Levothyroxine—Convulsion—Vandetanib—thyroid cancer	0.000258	0.0128	CcSEcCtD
Levothyroxine—Arthralgia—Vandetanib—thyroid cancer	0.000253	0.0126	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000253	0.0126	CcSEcCtD
Levothyroxine—Anxiety—Vandetanib—thyroid cancer	0.000252	0.0126	CcSEcCtD
Levothyroxine—Myocardial infarction—Sorafenib—thyroid cancer	0.000252	0.0125	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000221	0.011	CcSEcCtD
Levothyroxine—Insomnia—Vandetanib—thyroid cancer	0.000219	0.0109	CcSEcCtD
Levothyroxine—Dyspnoea—Vandetanib—thyroid cancer	0.000216	0.0108	CcSEcCtD
Levothyroxine—Flushing—Sorafenib—thyroid cancer	0.000214	0.0106	CcSEcCtD
Levothyroxine—Fatigue—Vandetanib—thyroid cancer	0.000209	0.0104	CcSEcCtD
Levothyroxine—Arrhythmia—Sorafenib—thyroid cancer	0.000206	0.0102	CcSEcCtD
Levothyroxine—Alopecia—Sorafenib—thyroid cancer	0.000204	0.0101	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000198	0.00988	CcSEcCtD
Levothyroxine—Abdominal pain—Vandetanib—thyroid cancer	0.000192	0.00955	CcSEcCtD
Levothyroxine—Body temperature increased—Vandetanib—thyroid cancer	0.000192	0.00955	CcSEcCtD
Levothyroxine—ALB—lymph node—thyroid cancer	0.000192	0.00829	CbGeAlD
Levothyroxine—Angioedema—Sorafenib—thyroid cancer	0.000183	0.00912	CcSEcCtD
Levothyroxine—Asthenia—Vandetanib—thyroid cancer	0.000174	0.00867	CcSEcCtD
Levothyroxine—Pruritus—Vandetanib—thyroid cancer	0.000172	0.00855	CcSEcCtD
Levothyroxine—Arthralgia—Sorafenib—thyroid cancer	0.000171	0.0085	CcSEcCtD
Levothyroxine—Diarrhoea—Vandetanib—thyroid cancer	0.000166	0.00826	CcSEcCtD
Levothyroxine—Shock—Sorafenib—thyroid cancer	0.000161	0.00802	CcSEcCtD
Levothyroxine—Coma—Epirubicin—thyroid cancer	0.000155	0.00771	CcSEcCtD
Levothyroxine—Vomiting—Vandetanib—thyroid cancer	0.000154	0.00768	CcSEcCtD
Levothyroxine—Rash—Vandetanib—thyroid cancer	0.000153	0.00762	CcSEcCtD
Levothyroxine—Dermatitis—Vandetanib—thyroid cancer	0.000153	0.00761	CcSEcCtD
Levothyroxine—Headache—Vandetanib—thyroid cancer	0.000152	0.00757	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000149	0.00742	CcSEcCtD
Levothyroxine—Dyspnoea—Sorafenib—thyroid cancer	0.000146	0.00726	CcSEcCtD
Levothyroxine—Nausea—Vandetanib—thyroid cancer	0.000144	0.00717	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—thyroid cancer	0.000143	0.00714	CcSEcCtD
Levothyroxine—Fatigue—Sorafenib—thyroid cancer	0.000141	0.00702	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000136	0.00676	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000134	0.00666	CcSEcCtD
Levothyroxine—ABCB1—trachea—thyroid cancer	0.000131	0.00569	CbGeAlD
Levothyroxine—Increased appetite—Epirubicin—thyroid cancer	0.000131	0.00652	CcSEcCtD
Levothyroxine—Urticaria—Sorafenib—thyroid cancer	0.00013	0.00647	CcSEcCtD
Levothyroxine—Abdominal pain—Sorafenib—thyroid cancer	0.000129	0.00644	CcSEcCtD
Levothyroxine—Body temperature increased—Sorafenib—thyroid cancer	0.000129	0.00644	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000126	0.00628	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—thyroid cancer	0.000126	0.00628	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000126	0.00625	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—thyroid cancer	0.000121	0.00603	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—thyroid cancer	0.000121	0.00603	CcSEcCtD
Levothyroxine—Asthenia—Sorafenib—thyroid cancer	0.000117	0.00585	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—thyroid cancer	0.000117	0.00583	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000117	0.00581	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—thyroid cancer	0.000117	0.00581	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—thyroid cancer	0.000117	0.0058	CcSEcCtD
Levothyroxine—Pruritus—Sorafenib—thyroid cancer	0.000116	0.00576	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—thyroid cancer	0.000114	0.0057	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—thyroid cancer	0.000112	0.00558	CcSEcCtD
Levothyroxine—Diarrhoea—Sorafenib—thyroid cancer	0.000112	0.00557	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—thyroid cancer	0.000109	0.0054	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000108	0.00539	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—thyroid cancer	0.000108	0.00537	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—thyroid cancer	0.000106	0.0053	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—thyroid cancer	0.000106	0.00527	CcSEcCtD
Levothyroxine—Vomiting—Sorafenib—thyroid cancer	0.000104	0.00518	CcSEcCtD
Levothyroxine—ABCB1—thyroid gland—thyroid cancer	0.000104	0.0045	CbGeAlD
Levothyroxine—Angina pectoris—Epirubicin—thyroid cancer	0.000104	0.00516	CcSEcCtD
Levothyroxine—Rash—Sorafenib—thyroid cancer	0.000103	0.00514	CcSEcCtD
Levothyroxine—Dermatitis—Sorafenib—thyroid cancer	0.000103	0.00513	CcSEcCtD
Levothyroxine—Headache—Sorafenib—thyroid cancer	0.000103	0.0051	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—thyroid cancer	0.0001	0.005	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—thyroid cancer	9.84e-05	0.0049	CcSEcCtD
Levothyroxine—Nausea—Sorafenib—thyroid cancer	9.72e-05	0.00484	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—thyroid cancer	9.62e-05	0.00479	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—thyroid cancer	9.59e-05	0.00477	CcSEcCtD
Levothyroxine—ABCB1—head—thyroid cancer	9.23e-05	0.00399	CbGeAlD
Levothyroxine—Sweating—Epirubicin—thyroid cancer	9.09e-05	0.00453	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—thyroid cancer	8.91e-05	0.00443	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—thyroid cancer	8.41e-05	0.00419	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—thyroid cancer	7.9e-05	0.00393	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—thyroid cancer	7.61e-05	0.00379	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—thyroid cancer	7.52e-05	0.00375	CcSEcCtD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—CP—thyroid cancer	7.38e-05	0.00297	CbGpPWpGaD
Levothyroxine—Flushing—Doxorubicin—thyroid cancer	7.31e-05	0.00364	CcSEcCtD
Levothyroxine—Tension—Epirubicin—thyroid cancer	7.27e-05	0.00362	CcSEcCtD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.26e-05	0.00293	CbGpPWpGaD
Levothyroxine—Nervousness—Epirubicin—thyroid cancer	7.2e-05	0.00358	CcSEcCtD
Levothyroxine—TTR—Disease—TRIM33—thyroid cancer	7.08e-05	0.00285	CbGpPWpGaD
Levothyroxine—Arrhythmia—Doxorubicin—thyroid cancer	7.04e-05	0.0035	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.01e-05	0.00283	CbGpPWpGaD
Levothyroxine—Alopecia—Doxorubicin—thyroid cancer	6.96e-05	0.00347	CcSEcCtD
Levothyroxine—THRB—Generic Transcription Pathway—RXRA—thyroid cancer	6.83e-05	0.00275	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—RXRA—thyroid cancer	6.83e-05	0.00275	CbGpPWpGaD
Levothyroxine—Agitation—Epirubicin—thyroid cancer	6.81e-05	0.00339	CcSEcCtD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.76e-05	0.00272	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—CP—thyroid cancer	6.76e-05	0.00272	CbGpPWpGaD
Levothyroxine—Tension—Doxorubicin—thyroid cancer	6.73e-05	0.00335	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—thyroid cancer	6.66e-05	0.00332	CcSEcCtD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.65e-05	0.00268	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	6.57e-05	0.00265	CbGpPWpGaD
Levothyroxine—Palpitations—Epirubicin—thyroid cancer	6.55e-05	0.00326	CcSEcCtD
Levothyroxine—ABCB1—lymph node—thyroid cancer	6.46e-05	0.00279	CbGeAlD
Levothyroxine—Convulsion—Epirubicin—thyroid cancer	6.42e-05	0.0032	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—thyroid cancer	6.31e-05	0.00314	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—thyroid cancer	6.3e-05	0.00314	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—thyroid cancer	6.29e-05	0.00313	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—thyroid cancer	6.1e-05	0.00304	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—thyroid cancer	6.06e-05	0.00302	CcSEcCtD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.04e-05	0.00243	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.04e-05	0.00243	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	5.95e-05	0.0024	CbGpPWpGaD
Levothyroxine—Shock—Epirubicin—thyroid cancer	5.95e-05	0.00296	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—thyroid cancer	5.94e-05	0.00296	CcSEcCtD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	5.92e-05	0.00239	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	5.92e-05	0.00239	CbGpPWpGaD
Levothyroxine—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.91e-05	0.00238	CbGpPWpGaD
Levothyroxine—Tachycardia—Epirubicin—thyroid cancer	5.9e-05	0.00294	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—thyroid cancer	5.85e-05	0.00291	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—thyroid cancer	5.84e-05	0.00291	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—thyroid cancer	5.82e-05	0.0029	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—thyroid cancer	5.64e-05	0.00281	CcSEcCtD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	5.64e-05	0.00227	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	5.59e-05	0.00225	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IFNA2—thyroid cancer	5.55e-05	0.00224	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.52e-05	0.00223	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	5.51e-05	0.00274	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—thyroid cancer	5.51e-05	0.00274	CcSEcCtD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.51e-05	0.00222	CbGpPWpGaD
Levothyroxine—Insomnia—Epirubicin—thyroid cancer	5.47e-05	0.00272	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—thyroid cancer	5.46e-05	0.00272	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—thyroid cancer	5.41e-05	0.00269	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—thyroid cancer	5.39e-05	0.00268	CcSEcCtD
Levothyroxine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	5.25e-05	0.00211	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CALCB—thyroid cancer	5.23e-05	0.00211	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—TPR—thyroid cancer	5.22e-05	0.00211	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—TPR—thyroid cancer	5.22e-05	0.00211	CbGpPWpGaD
Levothyroxine—Fatigue—Epirubicin—thyroid cancer	5.22e-05	0.0026	CcSEcCtD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	5.12e-05	0.00206	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	5.1e-05	0.00254	CcSEcCtD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.07e-05	0.00204	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.07e-05	0.00204	CbGpPWpGaD
Levothyroxine—Insomnia—Doxorubicin—thyroid cancer	5.06e-05	0.00252	CcSEcCtD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	5.06e-05	0.00204	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	5.06e-05	0.00204	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.06e-05	0.00204	CbGpPWpGaD
Levothyroxine—Dyspnoea—Doxorubicin—thyroid cancer	4.99e-05	0.00248	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—thyroid cancer	4.99e-05	0.00248	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—TRIM33—thyroid cancer	4.96e-05	0.002	CbGpPWpGaD
Levothyroxine—Gastrointestinal pain—Epirubicin—thyroid cancer	4.95e-05	0.00246	CcSEcCtD
Levothyroxine—THRB—Gene Expression—MEN1—thyroid cancer	4.91e-05	0.00198	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MEN1—thyroid cancer	4.91e-05	0.00198	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—MINPP1—thyroid cancer	4.84e-05	0.00195	CbGpPWpGaD
Levothyroxine—Fatigue—Doxorubicin—thyroid cancer	4.83e-05	0.0024	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—thyroid cancer	4.81e-05	0.00239	CcSEcCtD
Levothyroxine—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.79e-05	0.00193	CbGpPWpGaD
Levothyroxine—Body temperature increased—Epirubicin—thyroid cancer	4.78e-05	0.00238	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—thyroid cancer	4.78e-05	0.00238	CcSEcCtD
Levothyroxine—TTR—Disease—TCF7L1—thyroid cancer	4.72e-05	0.0019	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.71e-05	0.0019	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.64e-05	0.00187	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	4.63e-05	0.00187	CbGpPWpGaD
Levothyroxine—Feeling abnormal—Doxorubicin—thyroid cancer	4.61e-05	0.0023	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—thyroid cancer	4.58e-05	0.00228	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—thyroid cancer	4.45e-05	0.00221	CcSEcCtD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	4.43e-05	0.00179	CbGpPWpGaD
Levothyroxine—Abdominal pain—Doxorubicin—thyroid cancer	4.42e-05	0.0022	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—thyroid cancer	4.42e-05	0.0022	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—thyroid cancer	4.34e-05	0.00216	CcSEcCtD
Levothyroxine—THRA—Generic Transcription Pathway—PPARG—thyroid cancer	4.31e-05	0.00174	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—PPARG—thyroid cancer	4.31e-05	0.00174	CbGpPWpGaD
Levothyroxine—Pruritus—Epirubicin—thyroid cancer	4.28e-05	0.00213	CcSEcCtD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.25e-05	0.00171	CbGpPWpGaD
Levothyroxine—Diarrhoea—Epirubicin—thyroid cancer	4.14e-05	0.00206	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—NDUFA13—thyroid cancer	4.12e-05	0.00166	CbGpPWpGaD
Levothyroxine—Asthenia—Doxorubicin—thyroid cancer	4.02e-05	0.002	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—thyroid cancer	3.96e-05	0.00197	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—CHST14—thyroid cancer	3.87e-05	0.00156	CbGpPWpGaD
Levothyroxine—Vomiting—Epirubicin—thyroid cancer	3.85e-05	0.00191	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—thyroid cancer	3.83e-05	0.00191	CcSEcCtD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—TPR—thyroid cancer	3.83e-05	0.00154	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—CP—thyroid cancer	3.83e-05	0.00154	CbGpPWpGaD
Levothyroxine—Rash—Epirubicin—thyroid cancer	3.81e-05	0.0019	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—thyroid cancer	3.81e-05	0.0019	CcSEcCtD
Levothyroxine—SLCO1A2—Metabolism—MINPP1—thyroid cancer	3.81e-05	0.00153	CbGpPWpGaD
Levothyroxine—Headache—Epirubicin—thyroid cancer	3.79e-05	0.00189	CcSEcCtD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	3.79e-05	0.00153	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.77e-05	0.00152	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	3.7e-05	0.00149	CbGpPWpGaD
Levothyroxine—Nausea—Epirubicin—thyroid cancer	3.59e-05	0.00179	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—thyroid cancer	3.56e-05	0.00177	CcSEcCtD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	3.54e-05	0.00143	CbGpPWpGaD
Levothyroxine—Rash—Doxorubicin—thyroid cancer	3.53e-05	0.00176	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—thyroid cancer	3.53e-05	0.00176	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—thyroid cancer	3.51e-05	0.00175	CcSEcCtD
Levothyroxine—TTR—Disease—TPR—thyroid cancer	3.46e-05	0.00139	CbGpPWpGaD
Levothyroxine—TTR—Disease—PRKAR1A—thyroid cancer	3.4e-05	0.00137	CbGpPWpGaD
Levothyroxine—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.4e-05	0.00137	CbGpPWpGaD
Levothyroxine—Nausea—Doxorubicin—thyroid cancer	3.32e-05	0.00165	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—TCF7L1—thyroid cancer	3.31e-05	0.00133	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—RXRA—thyroid cancer	3.29e-05	0.00132	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—RXRA—thyroid cancer	3.29e-05	0.00132	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MINPP1—thyroid cancer	3.25e-05	0.00131	CbGpPWpGaD
Levothyroxine—TTR—Disease—MEN1—thyroid cancer	3.25e-05	0.00131	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	3.24e-05	0.0013	CbGpPWpGaD
Levothyroxine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.17e-05	0.00128	CbGpPWpGaD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.16e-05	0.00127	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—HPGD—thyroid cancer	3.12e-05	0.00126	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CHST14—thyroid cancer	3.04e-05	0.00123	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	3.01e-05	0.00121	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	3.01e-05	0.00121	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.96e-05	0.00119	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	2.89e-05	0.00117	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	2.89e-05	0.00117	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.86e-05	0.00116	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	2.77e-05	0.00112	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.71e-05	0.00109	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.69e-05	0.00108	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CHST14—thyroid cancer	2.6e-05	0.00105	CbGpPWpGaD
Levothyroxine—TTR—Disease—CALCA—thyroid cancer	2.59e-05	0.00104	CbGpPWpGaD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.57e-05	0.00104	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.57e-05	0.00104	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	2.57e-05	0.00104	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—RXRA—thyroid cancer	2.55e-05	0.00103	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.53e-05	0.00102	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.53e-05	0.00102	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—HPGD—thyroid cancer	2.45e-05	0.000989	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TSHR—thyroid cancer	2.42e-05	0.000976	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.41e-05	0.00097	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PRKAR1A—thyroid cancer	2.38e-05	0.00096	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDK1—thyroid cancer	2.34e-05	0.000944	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MEN1—thyroid cancer	2.28e-05	0.000918	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.25e-05	0.000907	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	2.16e-05	0.000873	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	2.15e-05	0.000866	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—HPGD—thyroid cancer	2.1e-05	0.000845	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—PPARG—thyroid cancer	2.07e-05	0.000836	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—PPARG—thyroid cancer	2.07e-05	0.000836	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—NRAS—thyroid cancer	2.07e-05	0.000835	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTCH1—thyroid cancer	2.06e-05	0.00083	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	2.04e-05	0.000822	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.99e-05	0.000802	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.92e-05	0.000776	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.89e-05	0.000762	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SST—thyroid cancer	1.88e-05	0.000759	CbGpPWpGaD
Levothyroxine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	1.88e-05	0.000758	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRG1—thyroid cancer	1.88e-05	0.000758	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MINPP1—thyroid cancer	1.87e-05	0.000754	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MINPP1—thyroid cancer	1.86e-05	0.00075	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CALCA—thyroid cancer	1.81e-05	0.000731	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TPR—thyroid cancer	1.79e-05	0.000723	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—KRAS—thyroid cancer	1.78e-05	0.000719	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	1.76e-05	0.000711	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.7e-05	0.000686	CbGpPWpGaD
Levothyroxine—TTR—Disease—TERT—thyroid cancer	1.69e-05	0.000681	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PRKAR1A—thyroid cancer	1.67e-05	0.000673	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDK1—thyroid cancer	1.64e-05	0.000661	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MINPP1—thyroid cancer	1.63e-05	0.000657	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.62e-05	0.000652	CbGpPWpGaD
Levothyroxine—TTR—Disease—HIF1A—thyroid cancer	1.61e-05	0.000651	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TP53—thyroid cancer	1.61e-05	0.000649	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.6e-05	0.000644	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	1.59e-05	0.000641	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TP53—thyroid cancer	1.58e-05	0.000639	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NDUFA13—thyroid cancer	1.58e-05	0.000637	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—HRAS—thyroid cancer	1.51e-05	0.000611	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CHST14—thyroid cancer	1.49e-05	0.000603	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CHST14—thyroid cancer	1.49e-05	0.000599	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	1.47e-05	0.000592	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	1.47e-05	0.000592	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.45e-05	0.000583	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TPR—thyroid cancer	1.41e-05	0.000568	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	1.39e-05	0.000559	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.39e-05	0.000558	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.37e-05	0.000551	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	1.34e-05	0.000541	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—AKT1—thyroid cancer	1.34e-05	0.000539	CbGpPWpGaD
Levothyroxine—TTR—Disease—BRAF—thyroid cancer	1.34e-05	0.000539	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRG1—thyroid cancer	1.32e-05	0.000531	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CHST14—thyroid cancer	1.3e-05	0.000525	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.29e-05	0.000519	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.29e-05	0.000519	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.27e-05	0.000511	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.26e-05	0.000507	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.26e-05	0.000506	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HPGD—thyroid cancer	1.2e-05	0.000486	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TPR—thyroid cancer	1.2e-05	0.000486	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HPGD—thyroid cancer	1.2e-05	0.000483	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.19e-05	0.00048	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	1.18e-05	0.000478	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TERT—thyroid cancer	1.18e-05	0.000477	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HIF1A—thyroid cancer	1.13e-05	0.000456	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—RXRA—thyroid cancer	1.13e-05	0.000455	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNA2—thyroid cancer	1.11e-05	0.000446	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.1e-05	0.000443	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.1e-05	0.000442	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTGS2—thyroid cancer	1.08e-05	0.000435	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.07e-05	0.000433	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	1.05e-05	0.000425	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HPGD—thyroid cancer	1.05e-05	0.000423	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.01e-05	0.000408	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1e-05	0.000405	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.88e-06	0.000398	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.77e-06	0.000394	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.72e-06	0.000392	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.64e-06	0.000388	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTEN—thyroid cancer	9.42e-06	0.00038	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—BRAF—thyroid cancer	9.36e-06	0.000377	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.24e-06	0.000373	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.15e-06	0.000369	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	9.02e-06	0.000363	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—RXRA—thyroid cancer	8.86e-06	0.000357	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.83e-06	0.000356	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.62e-06	0.000347	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	8.53e-06	0.000344	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.45e-06	0.000341	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRAS—thyroid cancer	8.4e-06	0.000339	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—AKT1—thyroid cancer	8.2e-06	0.000331	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—AKT1—thyroid cancer	8.2e-06	0.000331	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.1e-06	0.000326	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CHST14—thyroid cancer	8.02e-06	0.000323	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—RXRA—thyroid cancer	7.57e-06	0.000305	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.37e-06	0.000297	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—thyroid cancer	7.23e-06	0.000292	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—thyroid cancer	7.12e-06	0.000287	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TPR—thyroid cancer	6.92e-06	0.000279	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TPR—thyroid cancer	6.88e-06	0.000277	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—thyroid cancer	6.83e-06	0.000275	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	6.81e-06	0.000274	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.78e-06	0.000273	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PRKAR1A—thyroid cancer	6.77e-06	0.000273	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—thyroid cancer	6.59e-06	0.000266	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPGD—thyroid cancer	6.47e-06	0.000261	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.17e-06	0.000249	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—thyroid cancer	6.15e-06	0.000248	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.14e-06	0.000247	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TPR—thyroid cancer	6.03e-06	0.000243	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.03e-06	0.000243	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	5.93e-06	0.000239	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—thyroid cancer	5.88e-06	0.000237	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—thyroid cancer	5.6e-06	0.000226	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—thyroid cancer	5.59e-06	0.000225	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—thyroid cancer	5.43e-06	0.000219	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	5.18e-06	0.000209	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	5.17e-06	0.000208	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A5—thyroid cancer	5.15e-06	0.000208	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.09e-06	0.000205	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—thyroid cancer	5.06e-06	0.000204	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—thyroid cancer	4.88e-06	0.000197	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.85e-06	0.000196	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.83e-06	0.000195	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—thyroid cancer	4.78e-06	0.000193	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A5—thyroid cancer	4.51e-06	0.000182	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—thyroid cancer	4.5e-06	0.000181	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—thyroid cancer	4.4e-06	0.000177	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RXRA—thyroid cancer	4.35e-06	0.000175	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RXRA—thyroid cancer	4.33e-06	0.000174	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—thyroid cancer	4.3e-06	0.000174	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.23e-06	0.000171	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.21e-06	0.00017	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—thyroid cancer	4.13e-06	0.000166	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—thyroid cancer	3.84e-06	0.000155	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—thyroid cancer	3.8e-06	0.000153	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RXRA—thyroid cancer	3.79e-06	0.000153	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—thyroid cancer	3.76e-06	0.000152	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TPR—thyroid cancer	3.71e-06	0.00015	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.65e-06	0.000147	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—thyroid cancer	3.55e-06	0.000143	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—thyroid cancer	3.28e-06	0.000132	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—thyroid cancer	3.16e-06	0.000127	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—thyroid cancer	3.02e-06	0.000122	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—thyroid cancer	2.81e-06	0.000113	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.78e-06	0.000112	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—thyroid cancer	2.75e-06	0.000111	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—thyroid cancer	2.73e-06	0.00011	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—thyroid cancer	2.66e-06	0.000107	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—thyroid cancer	2.39e-06	9.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RXRA—thyroid cancer	2.34e-06	9.42e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—thyroid cancer	2.21e-06	8.91e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—thyroid cancer	2.16e-06	8.72e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—thyroid cancer	2.15e-06	8.67e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—thyroid cancer	1.89e-06	7.62e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—thyroid cancer	1.89e-06	7.6e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—thyroid cancer	1.88e-06	7.59e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—thyroid cancer	1.87e-06	7.56e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—thyroid cancer	1.64e-06	6.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.48e-06	5.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.16e-06	4.68e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—thyroid cancer	1.09e-06	4.38e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—thyroid cancer	1.08e-06	4.36e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.01e-06	4.08e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—thyroid cancer	9.47e-07	3.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—thyroid cancer	5.83e-07	2.35e-05	CbGpPWpGaD
